Cover image not available

Lapatinib or trastuzumab in combination with an aromatase inhibitor for first treatment of metastatic breast cancer that is hormone-receptor and HER2 positive

National Institute for Health and Clinical Excellence

Publication Data

Title Lapatinib or trastuzumab in combination with an aromatase inhibitor for first treatment of metastatic breast cancer that is hormone-receptor and HER2 positive
Author National Institute for Health and Clinical Excellence
Publisher National Institute for Health and Clinical Excellence
Publication date 2012
Publication location Manchester
Language English

Descriptive Notes

Issued: June 2012.

Topics

Breast :: Cancer :: Chemotherapy :: England
Breast :: Cancer :: Chemotherapy :: Wales
Lapatinib
Trastuzumab
Enzyme inhibitors

Catalogue Data

OBNB ID GBB586377
ISBN 10 n/a
ISBN 13 n/a
Type BibliographicResource, Book
Dewey Classification 616.99449061

ISBD

P1053 1 online resource (48 pages).
P1042 Includes bibliographical references.

Buy a copy

OBNB doesn't sell books, but you may be able to find a copy at one of these websites:

Lapatinib or trastuzumab in combination with an aromatase inhibitor for first treatment of metastatic breast cancer that is hormone-receptor and HER2 positive by National Institute for Health and Clinical Excellence. Published by National Institute for Health and Clinical Excellence in 2012. Publication and catalogue information, links to buy online and reader comments.